Markets:

Overview

News

Currencies

International

Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

165.35 -0.33 (-0.20%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

24 25 Next >

NASDAQ:PODD qualifies as a high growth stock and is consolidating. ↗

November 27, 2024

INSULET CORP (NASDAQ:PODD)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

Via Chartmill

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.

November 20, 2024

From Insulet Corporation

Via Business Wire

Insulet to Present at Upcoming Investor Conferences

November 15, 2024

From Insulet Corporation

Via Business Wire

Top 4 Health Care Stocks That May Plunge This Quarter ↗

November 11, 2024

Via Benzinga

9 Analysts Have This To Say About Insulet ↗

November 06, 2024

Via Benzinga

Why NASDAQ:PODD qualifies as a high growth stock. ↗

November 04, 2024

Is INSULET CORP (NASDAQ:PODD) suited for high growth investing?

Via Chartmill

(PODD) - Analyzing Insulet's Short Interest ↗

October 25, 2024

Via Benzinga

S&P 500 Breaks 6,000 Points, Dow Soars Above 44,000, Small Caps Eye Strongest Week In 4 Years, Tesla Hits $1 Trillion: What's Driving Markets Friday? ↗

November 08, 2024

The S&P 500 index surged past the 6,000-point milestone, setting fresh record highs, and small-cap stocks are poised for their best weekly performance since April 2024 as investor optimism surrounding...

Via Benzinga

Topics Stocks

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues ↗

November 08, 2024

Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024.

Via Investor's Business Daily

High growth, ROE and relative strength for NASDAQ:PODD, growth investors may appreciate this. ↗

November 08, 2024

Evaluating INSULET CORP (NASDAQ:PODD) for Growth Investment Opportunities.

Via Chartmill

Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1)

November 07, 2024

From Insulet Corporation

Via Business Wire

Here's How Much $1000 Invested In Insulet 10 Years Ago Would Be Worth Today ↗

October 24, 2024

Via Benzinga

Is NASDAQ:PODD on the Verge of a Major Breakout as a Strong Growth Stock? ↗

October 23, 2024

Why INSULET CORP (NASDAQ:PODD) Is a Standout High-Growth Stock in a Consolidation Phase.

Via Chartmill

This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

November 06, 2024

Via Benzinga

Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November

November 01, 2024

From Insulet Corporation 

Via Business Wire

Omnipod® 5 App for iPhone® Now Fully Available in the United States

October 29, 2024

From Insulet Corporation

Via Business Wire

Solventum Stock Earns 81 RS Rating ↗

October 15, 2024

Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.

Via Investor's Business Daily

If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today ↗

October 15, 2024

Via Benzinga

Analyst Ratings For Insulet ↗

October 14, 2024

Via Benzinga

Is NASDAQ:PODD a Fit for high Growth Investing Strategies? ↗

October 10, 2024

Is INSULET CORP (NASDAQ:PODD) suited for high growth investing?

Via Chartmill

Exploring the Growth Potential of NASDAQ:PODD as It Nears a Breakout. ↗

October 02, 2024

Why INSULET CORP (NASDAQ:PODD) Is a Promising High-Growth Stock in the Midst of Consolidation.

Via Chartmill

Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024

September 30, 2024

From Insulet Corporation

Via Business Wire

Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today ↗

September 24, 2024

Via Benzinga

Analyst Expectations For Insulet's Future ↗

September 17, 2024

Via Benzinga

GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

September 17, 2024

Via Benzinga

Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today ↗

September 10, 2024

Via Benzinga

(PODD) - Analyzing Insulet's Short Interest ↗

August 30, 2024

Via Benzinga

Upstart, Insulet And 2 Other Stocks Executives Are Selling ↗

September 12, 2024

Via Benzinga

Affirm, Mongodb And Best Buy Are Among Top 10 Large Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio? ↗

September 02, 2024

Top-performing large-cap stocks from last week: AFRM, NTNX, MDB, BBY, GEV, TCOM, COO, PODD, VEEV, AZPN.

Via Benzinga

Why Insulet Stock Was Zooming Higher This Week ↗

August 30, 2024

The company had encouraging news to impart about its leading insulin pump.

Via The Motley Fool

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.